Pediatric Exclusivity Should Not Negate Generic Drug Exclusivity - Sen. Hatch

Pediatric exclusivity for a brandname drug should not run concurrently with 180-day exclusivity for a generic version of the drug, Sens. Hatch (R-Utah), DeWine (R-Ohio) and Dodd (D-Conn.) maintained in a letter to FDA Commissioner Henney.